DrugPatentWatch Database Preview
Hikma Farmaceutica Company Profile
What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?
HIKMA FARMACEUTICA has forty-seven approved drugs.
Summary for Hikma Farmaceutica
| US Patents: | 0 |
| Tradenames: | 43 |
| Ingredients: | 36 |
| NDAs: | 47 |
Drugs and US Patents for Hikma Farmaceutica
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Farmaceutica | GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 090963-001 | Sep 21, 2011 | AP | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Hikma Farmaceutica | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | levofloxacin | INJECTABLE;INJECTION | 091375-003 | Sep 16, 2011 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Hikma Farmaceutica | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | INJECTABLE;INJECTION | 076781-001 | Dec 26, 2006 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
